Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis
Citations per year, relative to LI Leishi LI Leishi (= 1×)
peers
Jianghua Chen
Countries citing papers authored by LI Leishi
Since
Specialization
Citations
This map shows the geographic impact of LI Leishi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by LI Leishi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites LI Leishi more than expected).
This network shows the impact of papers produced by LI Leishi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by LI Leishi. The network helps show where LI Leishi may publish in the future.
Co-authorship network of co-authors of LI Leishi
This figure shows the co-authorship network connecting the top 25 collaborators of LI Leishi.
A scholar is included among the top collaborators of LI Leishi based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with LI Leishi. LI Leishi is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Leishi, LI. (2009). Triptolide ameliorates podocyte injury induced by the terminal complement factor C5b-9 in vitro.5 indexed citations
2.
Leishi, LI. (2009). Triptolide ameliorates proteinuria and improves renal lesion in diabetic db/db mice.1 indexed citations
3.
Leishi, LI. (2009). Obesity-related glomerulopathy:body mass index and proteinuria.9 indexed citations
4.
Leishi, LI. (2009). Chronic complications in patients of type 2 diabetes with diabetic nephropathy.1 indexed citations
5.
Leishi, LI. (2007). Effects of a combined regime of tripterygium wilfordii plus ARB and emodin in treatment of IgA nephropathy.1 indexed citations
6.
Leishi, LI. (2007). A prospective study of multi-target therapy on refractory lupus nephritis.1 indexed citations
7.
Leishi, LI. (2007). Evaluation of renal vascular lesions using circulating endothelial cells in patients with lupus nephritis.2 indexed citations
8.
Leishi, LI. (2007). Continuous blood purification in the treatment of 1692 critical patients:A retrospective study.1 indexed citations
9.
Leishi, LI. (2006). Mycophenolate mofetil versus intravenous pulse cyclophosphamide for class IV plus V lupus nephritis.2 indexed citations
10.
Leishi, LI. (2006). Effect of immunoadsorption therapy in patients with lipoprotein glomerulopathy.1 indexed citations
11.
Leishi, LI. (2006). Deposition of amylin in the renal tissues of patients with diabetic nephropathy.1 indexed citations
12.
Leishi, LI. (2006). Clinical and immunological features of 1352 Chinese patients with lupus nephritis.2 indexed citations
13.
Leishi, LI. (2006). Combined therapy of rhein and benazepril for treatment of diabetic nephropathy in db/db mice.6 indexed citations
14.
Leishi, LI. (2006). Rate of declining residual renal function in patients on peritoneal dialysis.
15.
Leishi, LI. (2005). Assessment of insulin resistance in patients with obesity related glomerulopathy.1 indexed citations
16.
Leishi, LI. (2004). A prospective preliminary study of tacrolimus (FK506) combined with low-dose prednisone in patients with membranous lupus nephropathy.1 indexed citations
17.
Tang, Zheng, Yan Wu, Qingwen Wang, et al.. (2003). Clinical spectrum of diffuse crescentic glomerulonephritis in Chinese patients.. PubMed. 116(11). 1737–40.19 indexed citations
18.
Leishi, LI. (2003). Glomerular podocyte lesion in patients with diabetic nephropathy.3 indexed citations
19.
Chen, Shufen, Zhihong Liu, Huiping Chen, et al.. (2002). Glomerular chemokine expression and the effect of steroid and cyclophosphamide pulse therapy in human crescentic glomerulonephritis.. PubMed. 115(9). 1301–7.5 indexed citations
20.
Tang, Zheng, et al.. (1997). Effects of methylprednisolone and cyclophosphamide pulse therapy on renal infiltrating cells in patients with crescentic glomerulonephritis.. PubMed. 110(3). 206–9.4 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.